Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 185676, 10 pages
http://dx.doi.org/10.1155/2014/185676
Research Article

Antidiabetic Activity of Artemisia amygdalina Decne in Streptozotocin Induced Diabetic Rats

1Department of Biochemistry, Faculty of Biological Sciences, University of Kashmir, Srinagar 190 006, India
2Drug Standardisation Research Unit, Regional Research Institute of Unani Medicine (CCRUM), University of Kashmir, Naseem Bagh, Srinagar 190 006, India
3Centre of Research for Development, University of Kashmir, Srinagar 190 006, India

Received 7 February 2014; Revised 10 April 2014; Accepted 24 April 2014; Published 21 May 2014

Academic Editor: Gianluca Bardini

Copyright © 2014 Khalid Ghazanfar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Imam, “Clinical features, diagnostic criteria and pathogenesis of diabetes mellitus,” Journal of Advances in Experimental Medicine and Biology, vol. 771, pp. 340–355, 2012. View at Google Scholar
  2. A. Elosta, T. Ghous, and N. Ahmed, “Natural products as Anti-glycation agents: possible therapeutic potential for diabetic complications,” Current Diabetes Reviews, vol. 8, no. 2, pp. 92–108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. International Diabetes Federation IDF, Diabetes Atlas, 5th edition, 2012.
  4. H. A. Spiller and T. S. Sawyer, “Toxicology of oral antidiabetic medications,” American Journal of Health-System Pharmacy, vol. 63, no. 10, pp. 929–938, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. T. Eurich, F. A. McAlister, D. F. Blackburn et al., “Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review,” British Medical Journal, vol. 335, no. 7618, pp. 497–501, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Saxena and N. K. Vikram, “Role of selected Indian plants in management of type 2 diabetes: a review,” The Journal of Alternative and Complementary Medicine, vol. 10, no. 2, pp. 369–378, 2004. View at Google Scholar · View at Scopus
  7. M. Jung, M. Park, H. C. Lee, Y.-H. Kan, E. S. Kang, and S. K. Kim, “Antidiabetic agents from medicinal plants,” Current Medicinal Chemistry, vol. 13, no. 10, pp. 1203–1218, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Kachroo and I. M. Nahvi, “Ethnobotany of Kashmiris,” in Forest Flora of Srinagar and Plants of Neighbourhood, Bishen Singh Mahendra Pal Singh, Dehra Dun, India, 1987. View at Google Scholar
  9. U. Dhar and P. Kachroo, Alpine Flora of Kashmir Himalaya, Scientific publishers, Jodhpur, India, 1983.
  10. G. A. Guna, Medicinal flora of Kashmir valley [Ph.D. thesis], University of Kashmir, Srinagar, India, 2006.
  11. M. Ashraf, M. Q. Hayat, S. Jabeen, N. Shaheen, M. A. Khan, and G. Yasmin, “Artemisia L. species recognized by the local community of northern areas of Pakistan as folk therapeutic plants,” Journal of Medicinal Plant Research, vol. 4, no. 2, pp. 112–119, 2010. View at Google Scholar · View at Scopus
  12. M. Willcox, “Artemisia species: from traditional medicines to modern antimalarials—and back again,” The Journal of Alternative and Complementary Medicine, vol. 15, no. 2, pp. 101–109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Rasool, B. A. Ganai, S. Akbar, and A. N. Kamili, “Free radical scavenging potential of in vitro raised and greenhouse acclimatized plants of Artemisia amygdalina,” Chinese Journal of Natural Medicines, vol. 4, no. 11, pp. 377–384, 2013. View at Google Scholar
  14. A. R. Dar, G. H. Dar, and R. Zafar, “Conservation of Artemisia amygdalina—acritically endangered endemic plant species of Kashmir Himalaya,” Endangered Species Update, vol. 23, no. 1, pp. 34–39, 2006. View at Google Scholar
  15. S. K. Sivagnanam, R. K. Rao, Mudiganti, U. M. Dar, and P. G. Jeelani, “Preliminary phytochemical analysis of Artemisia amygdalina, Nerium odorum and Strychnos potatorum,” Journal of Pharmacy Research, vol. 5, no. 7, pp. 3734–3739, 2012. View at Google Scholar
  16. R. Rasool, B. A. Ganai, A. N. Kamili, and S. Akbar, “Antioxidant potential in callus culture of Artemisia amygdalina Decne,” Natural Product Research, vol. 26, no. 22, pp. 2103–2106, 2012. View at Google Scholar
  17. K. Mubashir, B. A. Ganai, K. Ghazanfar, S. Akbar, A. H. Malik, and A. Masood, “Evaluation of Artemisia amygdalina D. for anti-Inflammatory and immunomodulatory potential,” ISRN Inflammation, vol. 2013, Article ID 483646, 5 pages, 2013. View at Publisher · View at Google Scholar
  18. M. Qaisar, “Asteraceae,” Flora of Pakistan, vol. 207, pp. 120–121, 2006. View at Google Scholar
  19. S. H. Lone, K. A. Bhat, S. Naseer, R. A. Rather, M. A. Khuroo, and S. A. Tasduq, “Isolation, cytotoxicity evaluation and HPLC-quantification of the chemical constituents from Artemisia amygdalina Decne,” Journal of Chromatography B, vol. 940, pp. 135–141, 2013. View at Google Scholar
  20. M. A. Rather, B. A. Ganai, A. N. Kamili et al., “Comparative GC-FID and GC-MS analysis of the mono and sesquiterpene secondary metabolites produced by the field grown and micropropagated plants of Artemisia amygdalina Decne,” Acta Physiologiae Plantarum, vol. 34, no. 3, pp. 885–890, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. OECD, “OECD guidelines for the testing of chemicals,” Test 425, 2008. View at Google Scholar
  22. N. V. Thakkar and J. A. Patel, “Pharmacological evaluation of “glyoherb”: a polyherbal formulation on streptozotocin-induced diabetic rats,” International Journal of Diabetes in Developing Countries, vol. 30, no. 1, pp. 1–7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Sabitha, S. Ramachandran, K. R. Naveen, and K. Panneerselvam, “Antidiabetic and antihyperlipidemic potential of Abelmoschus esculentus (L.) Moench. in streptozotocin-induced diabetic rats,” Journal of Pharmacy and Bioallied Sciences, vol. 3, no. 3, pp. 397–402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Ahmad, I. Khan, M. A. Khan, M. Ahmad, F. Subhan, and N. Karim, “Evaluation of antidiabetic and antihyperlipidemic activity of Artemisia indica linn (aeriel parts) in Streptozotocin induced diabetic rats,” Journal of Ethnopharmacology, vol. 151, no. 1, pp. 618–623, 2014. View at Google Scholar
  25. Y. Mohan, G. N. Jesuthankaraj, and N. R. Thangavelu, “Antidiabetic and antioxidant properties of Triticum aestivum in streptozotocin-induced diabetic rats,” Advances in Pharmacolological Sciences, vol. 2013, Article ID 716073, 9 pages, 2013. View at Publisher · View at Google Scholar
  26. T. F. Tzeng, S. S. Liou, C. J. Chang, and I. M. Liu, “The ethanol extract of Lonicera japonica (Japanese Honeysuckle) attenuates diabetic nephropathy by inhibiting p-8 MAPK activity in streptozotocin-induced diabetic rats,” Planta Medica, vol. 80, no. 2-3, pp. 121–139, 2014. View at Google Scholar
  27. C. W. Lee, H. S. Lee, Y. J. Cha, W. H. Joo, D. O. Kang, and J. Y. Moon, “In vivo Investigation of anti-diabetic properties of ripe onion juice in normal and streptozotocin-induced diabetic rats,” Preventive Nutrition and Food Science, vol. 18, no. 3, pp. 169–174, 2013. View at Google Scholar
  28. G. E. Trease and W. C. Evans, Textbook of Pharmacognosy, vol. 12, Balliese Tindall and Company Publisher, London, UK, 1983.
  29. K. M. Nadkarni and A. K. Nadkarni, Indian Materia Medica, vol. 1, Popular Prakashan, Bombay, India, 1976.
  30. W. Ahmad, I. Khan, M. A. Khan, M. Ahmad, F. Subhan, and N. Karim, “Evaluation of antidiabetic and antihyperlipidemic activity of Artemisia indica linn. (aeriel parts) in Streptozotocin induced diabetic rats,” Journal of Ethnopharmacology, vol. 151, pp. 618–623, 2013. View at Google Scholar
  31. S. M. Nofa, S. S. Mahmoud, A. Ramadan, G. A. Soliman, and R. Fawzy, “Anti-diabetic effect of Artemisia judaica extracts,” Research Journal of Medicine and Medical Sciences, vol. 4, no. 1, pp. 42–48, 2009. View at Google Scholar
  32. L. Al-Shamaony, S. M. Al-Khazraji, and H. A. A. Twaij, “Hypoglycaemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals,” Journal of Ethnopharmacology, vol. 43, no. 3, pp. 167–171, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Subramoniam, P. Pushpangadan, S. Rajasekharan, D. A. Evans, P. G. Latha, and R. Valsaraj, “Effects of Artemisia pallens Wall. on blood glucose levels in normal and alloxan-induced diabetic rats,” Journal of Ethnopharmacology, vol. 50, no. 1, pp. 13–17, 1996. View at Google Scholar
  34. K. Mansi, M. Amneh, and H. Nasr, “The hypolipidemic effects of Artemisia sieberi (A. herba-alba) in alloxan induced diabetic rats,” International Journal of Pharmacology, vol. 3, no. 6, pp. 487–491, 2007. View at Google Scholar · View at Scopus
  35. P. Daisy, J. Eliza, and S. Ignacimuthu, “Influence of Costus speciosus (Koen.) sm. rhizome extracts on biochemical parameters in streptozotocin induced diabetic rats,” Journal of Health Science, vol. 54, no. 6, pp. 675–681, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. D. H. Prisilla, R. Balamurugan, and H. R. Shah, “Antidiabetic activity of methanol extract of Acorus calamus in STZ induced diabetic rats,” Asian Pacific Journal of Tropical Biomedicine, vol. 2, no. 2, pp. 941–946, 2012. View at Google Scholar
  37. E. Adeghate and A. S. Ponery, “GABA in the endocrine pancreas: cellular localization and function in normal and diabetic rats,” Tissue and Cell, vol. 34, no. 1, pp. 1–6, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. G. A. Spinas, “The dual role of nitric oxide in islet β-cells,” News in Physiological Sciences, vol. 14, no. 2, pp. 49–54, 1999. View at Google Scholar · View at Scopus
  39. V. Kumar, R. Cotran, and S. Robbins, Basic Pathology, vol. 5, WB Saunders, Philadelphia, Pa, USA, 1992.
  40. A. T. Govan, P. S. Macfarlane, and R. Callander, Pathology Illustrated, vol. 2, Churchill Levingstone, New York, NY, USA, 1986.
  41. R. K. Gupta, D. Kumar, A. K. Chaudhary, M. Maithani, and R. Singh, “Antidiabetic activity of Passiflora incarnata Linn. in streptozotocin- induced diabetes in mice,” Journal of Ethnopharmacology, vol. 139, no. 3, pp. 801–806, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. S. K. Yadav, B. P. Nagori, and D. P. Kumar, “Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy,” Journal of Ethnopharmacology, vol. 152, no. 2, pp. 349–357, 2014. View at Google Scholar
  43. G. Brahmachari, “Six Bio-flavonoids with promising antidiabetic potentials: a critical survey,” in Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry, pp. 187–212, 2011. View at Google Scholar
  44. T. Arif, B. Sharma, A. Gahlaut, V. Kumar, and R. Dabur, “Anti- diabetic agents from medicinal plants: a review,” Chemical Biological Letters, vol. 1, no. 1, pp. 1–13, 2014. View at Google Scholar
  45. M. S. Deutschländer, N. Lall, M. van de Venter, and A. A. Hussein, “Hypoglycemic evaluation of a new triterpene and other compounds isolated from Euclea undulata Thunb. var. myrtina (Ebenaceae) root bark,” Journal of Ethnopharmacology, vol. 133, no. 3, pp. 1091–1095, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. V. J. Sharma and U. D. Shah, “Antihyperglycemic activity of flavonoids from methanolic extract of aerial parts of Scoparia dulcis in streptozotocin induced diabetic rats,” International Journal of ChemTech Research, vol. 2, no. 1, pp. 214–218, 2010. View at Google Scholar · View at Scopus
  47. A. Ghasemzadeh and N. Ghasemzadeh, “Flavonoids and phenolic acids: role and biochemical activity in plants and human,” Journal of Medicinal Plant Research, vol. 5, no. 31, pp. 6697–6703, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. M.-J. Tan, J.-M. Ye, N. Turner et al., “Antidiabetic Activities of Triterpenoids Isolated from Bitter Melon Associated with Activation of the AMPK Pathway,” Chemistry and Biology, vol. 15, no. 3, pp. 263–273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. S. A. Hussain and B. H. Marouf, “Flavonoids as alternatives in treatment of type 2 diabetes mellitus,” Academia Journal of Medicinal Plants, vol. 1, no. 2, pp. 31–36, 2013. View at Google Scholar